A detailed history of Saturn V Capital Management LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Saturn V Capital Management LLC holds 946,335 shares of CELC stock, worth $12.1 Million. This represents 5.04% of its overall portfolio holdings.

Number of Shares
946,335
Previous 760,941 24.36%
Holding current value
$12.1 Million
Previous $12.5 Billion 13.2%
% of portfolio
5.04%
Previous 4.71%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $2.59 Million - $3.55 Million
185,394 Added 24.36%
946,335 $14.1 Billion
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $10.7 Million - $15.8 Million
760,941 New
760,941 $12.5 Billion

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $191M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.